Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma (NCT03894917)
Characterizing Disease Biology, Treatment Patterns and Toxicity in Older Adults With Advanced Hepatocellular Carcinoma
🩺 Plain-English Summary (8th-Grade Level)
This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.
Who can join: Review the eligibility criteria below.
Location: Mays Cancer Center — San Antonio, Texas
Age range: 18 Years
🧪 Interventions in This Study
- Comprehensive Geriatric Assessment (CGA) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Mays Cancer Center — San Antonio, Texas
📞 Contact the Study Coordinator
Phone: (210) 450-0507
Email: tomasinim@uthscsa.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Carcinoma, Hepatocellular
- Case-Control Study of the Glycotest™ HCC Panel Vs AFP for the Detection of Early-stage Hepatocellular Carcinoma — Los Angeles, California
- Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. — Irvine, California
- National Liver Cancer Screening Trial — Los Angeles, California
- Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma — New Brunswick, New Jersey
- 90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia — New Orleans, Louisiana
Explore by condition: All Carcinoma, Hepatocellular clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.